,Table of Contents
fg fg
Chapter fg01 fgThe fgRole fgof fgthe fgAdvanced fgPractice fgNurse fgas fgPrescriber 1
Chapter fg02 fgReview fgof fgBasic fgPrinciples fgof fgPharmacology 2
Chapter fg03 fgRational fgDrug fgSelection 8
Chapter fg04 fgLegal fgand fgProfessional fgIssues fgin fgPrescribing 11
Chapter fg05 fgAdverse fgDrug fgReactions 13
Chapter fg06 fgAn fgIntroduction fgto fgPharmacogenomics 16
Chapter fg07 fgNutrition fgand fgNutraceuticals 19
Chapter fg08 fgHerbal fgTherapies 25
Chapter fg09 fgCannabis 28
Chapter fg10 fgPharmacoeconomics 32
Chapter fg11 fgDrugs fgAffecting fgthe fgAutonomic fgNervous fgSystem 35
Chapter fg12 fgDrugs fgAffecting fgthe fgCentral fgNervous fgSystem 42
Chapter fg13 fgDrugs fgAffecting fgthe fgCardiovascular fgand fgRenal fgSystems 50
Chapter fg14 fgDrugs fgAffecting fgthe fgRespiratory fgSystem 58
Chapter fg15 fgDrugs fgAffecting fgthe fgHematological fgSystem 62
Chapter fg16 fgDrugs fgAffecting fgthe fgImmune fgSystem: fgVaccines fgand fgImmunoglobulins 66
Chapter fg17 fgDrugs fgAffecting fgthe fgImmune fgSystem: fgImmunomodulators 72
Chapter fg18 fgDrugs fgAffecting fgthe fgGastrointestinal fgSystem 74
Chapter fg19 fgDrugs fgAffecting fgthe fgEndocrine fgSystem: fgPancreatic fgHormones fgand fgAntidiabetic
Drugs 77
Chapter fg20 fgDrugs fgAffecting fgthe fgEndocrine fgSystem: fgPituitary, fgThyroid, fgand fgAdrenal fgDrugs 80
Chapter fg21 fgDrugs fgAffecting fgthe fgReproductive fgSystem 83
Chapter fg22 fgDrugs fgAffecting fgthe fgBones fgand fgJoints 89
Chapter fg23 fgDrugs fgAffecting fgthe fgIntegumentary fgSystem 93
Chapter fg24 fgDrugs fgUsed fgto fgTreat fgBacterial fgInfections 98
Chapter fg25 fgDrugs fgUsed fgto fgTreat fgViral, fgFungal, fgand fgProtozoal fgInfections 102
Chapter fg26 fgDrugs fgUsed fgto fgTreat fgInflammatory fgProcesses 105
Chapter fg27 fgDrugs fgUsed fgto fgTreat fgEye fgand fgEar fgDisorders 108
Chapter fg28 fgAnemia 110
Chapter fg29 fgAnxiety fgand fgDepression 113
Chapter fg30 fgAttention fgDeficit-Hyperactivity fgDisorder 117
Chapter fg31 fgAsthma fgand fgAllergy 119
Chapter fg32 fgChronic fgObstructive fgPulmonary fgDisease 122
Chapter fg33 fgContraception 124
Chapter fg34 fgCOVID-19: fgAcute fgand fgChronic 127
Chapter fg35 fgDermatological fgConditions 131
Chapter fg36 fgDiabetes fgManagement 135
Chapter fg37 fgGastroesophageal fgReflux fgand fgPeptic fgUlcer fgDisease 143
Chapter fg38 fgHeadaches 146
Chapter fg39 fgHeart fgFailure 150
Chapter fg40 fgHIV fgDisease fgand fgAcquired fgImmunodeficiency fgSyndrome 155
,Chapter fg41 fgMenopausal fgHormone fgTherapy 158
Chapter fg42 fgHyperlipidemia 161
Chapter fg43 fgHypertension 166
Chapter fg44 fgHyperthyroidism fgand fgHypothyroidism 171
Chapter fg45 fgObesity 174
Chapter fg46 fgPain fgManagement: fgAcute fgand fgChronic fgPain 178
Chapter fg47 fgPneumonia 182
Chapter fg48 fgSexually fgTransmitted fgDiseases fgand fgVaginitis 184
Chapter fg49 fgSubstance fgUse fgDisorders 187
Chapter fg50 fgTuberculosis 192
Chapter fg51 fgUpper fgRespiratory fgTract fgInfection, fgPharyngitis, fgSinusitis, fgOtitis fgMedia, fgand
Otitis fgExterna 194
Chapter fg52 fgUrinary fgTract fgInfections 197
Chapter fg53 fgWomen fgas fgPatients 200
Chapter fg54 fgMen fgas fgPatients 204
Chapter fg55 fgPediatric fgPatients 206
Chapter fg56 fgTransgendered fgClients fgas fgPatients 208
Chapter fg57 fgGeriatric fgPatients 210
, Test fgBank fg- fgPharmacotherapeutics fgfor fgAdvanced fgPractice fgNurse fgPrescribers, fg6th fgEdition
(Woo, 2024)
Woo 1
Pharmacotherapeutics fgfor fgAPN fgPrescribers, Ch01
6e
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
fg fg fg fg fg fg fg fg fg fg
MULTIPLE fgCHOICE
1. Nurse fgpractitioner fgprescriptive fgauthority fgis fgregulated fgby:
A. The fgNational fgCouncil fgof fgState fgBoards fgof fgNursing
B. The fgU.S. fgDrug fgEnforcement fgAdministration
C. The fgState fgBoard fgof fgNursing fgfor fgeach fgstate
D. The fgState fgBoard fgof fgPharmacy
ANSWER: f g C PTS: f g fg 1
2. The fgbenefits fgto fgthe fgpatient fgof fghaving fgan fgadvanced fgpractice fgregistered fgnurse fg(APRN)
prescriber fginclude:
fg
A. Nurses fgknow fgmore fgabout fgpharmacology fgthan fgother fgprescribers fgbecause fgthey
take fgit fgboth fgin fgtheir fgbasic fgnursing fgprogram fgand fgin fgtheir fgAPRN fgprogram.
fg
B. Nurses fgcare fgfor fgthe fgpatient fgfrom fga fgholistic fgapproach fgand fginclude fgthe
patient fgin fgdecision-making fgregarding fgtheir fgcare.
fg
C. APRNs fgare fgless fglikely fgto fgprescribe fgnarcotics fgand fgother fgcontrolled fgsubstances.
D. APRNs fgare fgable fgto fgprescribe fgindependently fgin fgall fgstates, fgwhereas fga
fgphysician’s fgassistant fgneeds fgto fghave fga fgphysician fgsupervising fgtheir
fgpractice.
ANSWER: f g B PTS: f g fg 1
3. Clinical fgjudgment fgin fgprescribing fgincludes:
A. Factoring fgin fgthe fgcost fgto fgthe fgpatient fgof fgthe fgmedication fgprescribed
B. Always fgprescribing fgthe fgnewest fgmedication fgavailable fgfor fgthe fgdisease fgprocess
C. Handing fgout fgdrug fgsamples fgto fgpoor fgpatients
D. Prescribing fgall fggeneric fgmedications fgto fgcut fgcosts
ANSWER: f g A PTS: f g fg 1
4. The fgprocess fgfor fgchoosing fgan fgeffective fgdrug fgfor fga fgdisorder fgincludes:
A. Asking fgthe fgpatient fgwhat fgdrug fgthey fgthink fgwould fgwork fgbest fgfor fgthem
B. Consulting fgnationally fgrecognized fgguidelines fgfor fgdisease fgmanagement
C. Prescribing fgmedications fgthat fgare fgavailable fgas fgsamples fgbefore fgwriting fga fgprescription
D. Following fgU.S. fgDrug fgEnforcement fgAdministration fgguidelines fgfor fgprescribing
ANSWER: f g B PTS: f g fg 1
5. Nonintentional fgnonadherence fgof fgdrug fgtherapy fgmay fgoccur fgdue fgto:
A. Belief fgthat fgmedication fgdoes fgnot fgwork
B. Adverse fgdrug fgreactions
C. Chronic fgconditions fgthat fgrequire fgdaily fgtherapy
D. Forgetfulness fgor fgdistraction
ANSWER: f g D PTS: f g fg 1
1 fg| fgP fga fgg fge
fg fg
Chapter fg01 fgThe fgRole fgof fgthe fgAdvanced fgPractice fgNurse fgas fgPrescriber 1
Chapter fg02 fgReview fgof fgBasic fgPrinciples fgof fgPharmacology 2
Chapter fg03 fgRational fgDrug fgSelection 8
Chapter fg04 fgLegal fgand fgProfessional fgIssues fgin fgPrescribing 11
Chapter fg05 fgAdverse fgDrug fgReactions 13
Chapter fg06 fgAn fgIntroduction fgto fgPharmacogenomics 16
Chapter fg07 fgNutrition fgand fgNutraceuticals 19
Chapter fg08 fgHerbal fgTherapies 25
Chapter fg09 fgCannabis 28
Chapter fg10 fgPharmacoeconomics 32
Chapter fg11 fgDrugs fgAffecting fgthe fgAutonomic fgNervous fgSystem 35
Chapter fg12 fgDrugs fgAffecting fgthe fgCentral fgNervous fgSystem 42
Chapter fg13 fgDrugs fgAffecting fgthe fgCardiovascular fgand fgRenal fgSystems 50
Chapter fg14 fgDrugs fgAffecting fgthe fgRespiratory fgSystem 58
Chapter fg15 fgDrugs fgAffecting fgthe fgHematological fgSystem 62
Chapter fg16 fgDrugs fgAffecting fgthe fgImmune fgSystem: fgVaccines fgand fgImmunoglobulins 66
Chapter fg17 fgDrugs fgAffecting fgthe fgImmune fgSystem: fgImmunomodulators 72
Chapter fg18 fgDrugs fgAffecting fgthe fgGastrointestinal fgSystem 74
Chapter fg19 fgDrugs fgAffecting fgthe fgEndocrine fgSystem: fgPancreatic fgHormones fgand fgAntidiabetic
Drugs 77
Chapter fg20 fgDrugs fgAffecting fgthe fgEndocrine fgSystem: fgPituitary, fgThyroid, fgand fgAdrenal fgDrugs 80
Chapter fg21 fgDrugs fgAffecting fgthe fgReproductive fgSystem 83
Chapter fg22 fgDrugs fgAffecting fgthe fgBones fgand fgJoints 89
Chapter fg23 fgDrugs fgAffecting fgthe fgIntegumentary fgSystem 93
Chapter fg24 fgDrugs fgUsed fgto fgTreat fgBacterial fgInfections 98
Chapter fg25 fgDrugs fgUsed fgto fgTreat fgViral, fgFungal, fgand fgProtozoal fgInfections 102
Chapter fg26 fgDrugs fgUsed fgto fgTreat fgInflammatory fgProcesses 105
Chapter fg27 fgDrugs fgUsed fgto fgTreat fgEye fgand fgEar fgDisorders 108
Chapter fg28 fgAnemia 110
Chapter fg29 fgAnxiety fgand fgDepression 113
Chapter fg30 fgAttention fgDeficit-Hyperactivity fgDisorder 117
Chapter fg31 fgAsthma fgand fgAllergy 119
Chapter fg32 fgChronic fgObstructive fgPulmonary fgDisease 122
Chapter fg33 fgContraception 124
Chapter fg34 fgCOVID-19: fgAcute fgand fgChronic 127
Chapter fg35 fgDermatological fgConditions 131
Chapter fg36 fgDiabetes fgManagement 135
Chapter fg37 fgGastroesophageal fgReflux fgand fgPeptic fgUlcer fgDisease 143
Chapter fg38 fgHeadaches 146
Chapter fg39 fgHeart fgFailure 150
Chapter fg40 fgHIV fgDisease fgand fgAcquired fgImmunodeficiency fgSyndrome 155
,Chapter fg41 fgMenopausal fgHormone fgTherapy 158
Chapter fg42 fgHyperlipidemia 161
Chapter fg43 fgHypertension 166
Chapter fg44 fgHyperthyroidism fgand fgHypothyroidism 171
Chapter fg45 fgObesity 174
Chapter fg46 fgPain fgManagement: fgAcute fgand fgChronic fgPain 178
Chapter fg47 fgPneumonia 182
Chapter fg48 fgSexually fgTransmitted fgDiseases fgand fgVaginitis 184
Chapter fg49 fgSubstance fgUse fgDisorders 187
Chapter fg50 fgTuberculosis 192
Chapter fg51 fgUpper fgRespiratory fgTract fgInfection, fgPharyngitis, fgSinusitis, fgOtitis fgMedia, fgand
Otitis fgExterna 194
Chapter fg52 fgUrinary fgTract fgInfections 197
Chapter fg53 fgWomen fgas fgPatients 200
Chapter fg54 fgMen fgas fgPatients 204
Chapter fg55 fgPediatric fgPatients 206
Chapter fg56 fgTransgendered fgClients fgas fgPatients 208
Chapter fg57 fgGeriatric fgPatients 210
, Test fgBank fg- fgPharmacotherapeutics fgfor fgAdvanced fgPractice fgNurse fgPrescribers, fg6th fgEdition
(Woo, 2024)
Woo 1
Pharmacotherapeutics fgfor fgAPN fgPrescribers, Ch01
6e
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
fg fg fg fg fg fg fg fg fg fg
MULTIPLE fgCHOICE
1. Nurse fgpractitioner fgprescriptive fgauthority fgis fgregulated fgby:
A. The fgNational fgCouncil fgof fgState fgBoards fgof fgNursing
B. The fgU.S. fgDrug fgEnforcement fgAdministration
C. The fgState fgBoard fgof fgNursing fgfor fgeach fgstate
D. The fgState fgBoard fgof fgPharmacy
ANSWER: f g C PTS: f g fg 1
2. The fgbenefits fgto fgthe fgpatient fgof fghaving fgan fgadvanced fgpractice fgregistered fgnurse fg(APRN)
prescriber fginclude:
fg
A. Nurses fgknow fgmore fgabout fgpharmacology fgthan fgother fgprescribers fgbecause fgthey
take fgit fgboth fgin fgtheir fgbasic fgnursing fgprogram fgand fgin fgtheir fgAPRN fgprogram.
fg
B. Nurses fgcare fgfor fgthe fgpatient fgfrom fga fgholistic fgapproach fgand fginclude fgthe
patient fgin fgdecision-making fgregarding fgtheir fgcare.
fg
C. APRNs fgare fgless fglikely fgto fgprescribe fgnarcotics fgand fgother fgcontrolled fgsubstances.
D. APRNs fgare fgable fgto fgprescribe fgindependently fgin fgall fgstates, fgwhereas fga
fgphysician’s fgassistant fgneeds fgto fghave fga fgphysician fgsupervising fgtheir
fgpractice.
ANSWER: f g B PTS: f g fg 1
3. Clinical fgjudgment fgin fgprescribing fgincludes:
A. Factoring fgin fgthe fgcost fgto fgthe fgpatient fgof fgthe fgmedication fgprescribed
B. Always fgprescribing fgthe fgnewest fgmedication fgavailable fgfor fgthe fgdisease fgprocess
C. Handing fgout fgdrug fgsamples fgto fgpoor fgpatients
D. Prescribing fgall fggeneric fgmedications fgto fgcut fgcosts
ANSWER: f g A PTS: f g fg 1
4. The fgprocess fgfor fgchoosing fgan fgeffective fgdrug fgfor fga fgdisorder fgincludes:
A. Asking fgthe fgpatient fgwhat fgdrug fgthey fgthink fgwould fgwork fgbest fgfor fgthem
B. Consulting fgnationally fgrecognized fgguidelines fgfor fgdisease fgmanagement
C. Prescribing fgmedications fgthat fgare fgavailable fgas fgsamples fgbefore fgwriting fga fgprescription
D. Following fgU.S. fgDrug fgEnforcement fgAdministration fgguidelines fgfor fgprescribing
ANSWER: f g B PTS: f g fg 1
5. Nonintentional fgnonadherence fgof fgdrug fgtherapy fgmay fgoccur fgdue fgto:
A. Belief fgthat fgmedication fgdoes fgnot fgwork
B. Adverse fgdrug fgreactions
C. Chronic fgconditions fgthat fgrequire fgdaily fgtherapy
D. Forgetfulness fgor fgdistraction
ANSWER: f g D PTS: f g fg 1
1 fg| fgP fga fgg fge
